Is There Life After COMBACTE?
Much is being invested in the establishment of CLIN-Net and LAB-Net. Wouldn’t it be a shame if European society ceases to benefit from this after 2021? The answer is obvious. This story is about looking at the future and a fruitful cooperation. Prof. Dr. Marc Bonten (Scientific Coordinator COMBACTE) and Prof. Herman Goossens (Academic Lead COMBACTE-NET and LAB-Net, and Coordinator for PREPARE) share their views on the future existence of an active European network for clinical trials in infectious diseases: ECRAID.
ECRAID Piece
Related updates

COMBACTE Scientific Papers 2022: Part 2

POS-VAP Site Selection Completed

WAAW 2022: Preventing Antimicrobial Resistance Together
The World Antimicrobial Awareness Week (WAAW) was introduced by the World Health Organization (WHO) to increase global awareness of antimicrobial resi...